Finance

Lists
SPH:WSE
Sopharma AD
PLN 10.10
0.00%
(0.00) 1D
Sep 17, 4:33:25 PM GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for SPH...
Mkt. cap
1.36B
Avg. vol.
1.18K
Volume
0.00
52-wk high
PLN 12.75
52-wk low
PLN 6.04
Shares outstanding
134.80M
No. of employees
6K
Mkt. cap
1.36B
Avg. vol.
1.18K
Volume
0.00
52-wk high
PLN 12.75
52-wk low
PLN 6.04
Shares outstanding
134.80M
No. of employees
6K
About Sopharma AD
CEO-
Employees6.05K
Founded1933
Headquarters-
SectorPharmaceutical industry
Websitesopharmagroup.com
Previous reportsAll values in BGN
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in BGN
Sep 2024
Dec 2024
Sep 2025
Dec 2025
Revenue
543.31M
596.44M
641.57M
710.03M
Cost of goods sold
428.74M
475.85M
484.05M
537.91M
Cost of revenue
428.74M
475.85M
484.05M
537.91M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
75.92M
91.21M
91.96M
108.78M
Operating expense
94.03M
111.69M
113.18M
151.56M
Total operating expenses
522.77M
587.54M
597.23M
689.48M
Operating income
20.54M
8.90M
44.35M
20.55M
Other non operating income
588.00K
-2.10M
1.54M
-2.14M
EBT including unusual items
21.29M
17.34M
45.95M
25.24M
EBT excluding unusual items
20.70M
11.73M
46.84M
23.26M
Income tax expense
2.11M
4.91M
4.93M
711.00K
Effective tax rate
9.90%
28.33%
10.72%
2.82%
Other operating expenses
2.01M
5.22M
2.24M
17.30M
Net income
18.59M
11.87M
40.38M
22.74M
Net profit margin
3.42%
1.99%
6.29%
3.20%
Earnings per share
-
-
-
-
Interest and investment income
426.00K
166.00K
-
978.00K
Interest expense
-3.28M
-3.81M
-6.34M
-5.83M
Net interest expenses
-2.85M
-3.64M
-6.34M
-4.86M
Depreciation and amortization charges
16.06M
15.22M
18.38M
26.01M
EBITDA
36.59M
16.58M
73.29M
30.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps